Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
2024 Revenues of $16.5 billion reflect an increase of 6%, in local…
Veeda Group Rebrands as ‘Veeda Lifesciences’
AHMEDABAD, India, Jan. 2, 2025 /PRNewswire/ -- Veeda Group has unveiled a…
